Pardeep Nijhawan - Jan 8, 2024 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Pardeep Nijhawan
Stock symbol
EDSA
Transactions as of
Jan 8, 2024
Transactions value $
$0
Form type
4
Date filed
1/12/2024, 05:30 PM
Previous filing
Aug 4, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $0 +2.91K +2.93% $0.00 102K Jan 8, 2024 Direct F1, F2
holding EDSA Common Shares 337K Jan 8, 2024 Held by Pardeep Nijhawan Medicine Professional Corporation F2, F3
holding EDSA Common Shares 32.6K Jan 8, 2024 Held by The New Nijhawan Family Trust 2015 F2, F4
holding EDSA Common Shares 32K Jan 8, 2024 Held by The Digestive Health Clinic Inc. F2, F3
holding EDSA Common Shares 53.1K Jan 8, 2024 Held by 1968160 Ontario Inc. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
F2 Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
F3 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.